scispace - formally typeset
R

Ronald E. Ferrando

Researcher at Genentech

Publications -  30
Citations -  4644

Ronald E. Ferrando is an academic researcher from Genentech. The author has contributed to research in topics: Cancer & Beta (finance). The author has an hindex of 23, co-authored 30 publications receiving 4305 citations. Previous affiliations of Ronald E. Ferrando include University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

TL;DR: The results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Journal ArticleDOI

Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies

TL;DR: This work has developed linkage-specific antibodies that recognize polyubiquitin chains joined through lysine 63 (K63) or 48 (K48) and uses these antibodies to demonstrate that RIP1, which is essential for tumor necrosis factor-induced NF-kappaB activation, and IRAK1, who participates in signaling by interleukin-1beta and Toll-like receptors, both undergo polyubiquein editing in stimulated cells.
Journal ArticleDOI

Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

TL;DR: The data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.
Journal ArticleDOI

Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.

TL;DR: It is concluded that airway smooth muscle proliferation is a pathologic characteristic of subjects with mild to moderate asthma, however, smooth muscle cells in mild tomoderate asthma do not show hypertrophy or gene expression changes of a hypercontractile phenotype observed in vitro.